![]() |
市場調查報告書
商品編碼
1374407
超音波換能器全球市場規模、佔有率、產業趨勢分析報告:2023-2030 年按產品類型、最終應用、地區分類的展望與預測Global Ultrasound Transducer Market Size, Share & Industry Trends Analysis Report By Product Type, By End Use (Hospital, Clinic, Diagnostic Center, and ASCs), By Application, By Regional Outlook and Forecast, 2023 - 2030 |
預計到 2030 年,全球超音波換能器市場規模將達到 49 億美元,預測期內年複合成長率3.6%。 2022年市場規模為193.39萬輛,成長率為4.0%(2019-2022年)。
根據 KBV 基數矩陣中提出的分析,三星電子有限公司(三星集團)(三星麥迪遜有限公司)於 2020 年 10 月宣布,新型超音波系統 HERA W10 和椅式超音波系統 HERA I10 推出原型並交付改進的技術和產品,影像品質達到新的水平。 GE醫療保健技術有限公司、深圳邁瑞生物醫療電子有限公司和日立公司(日立醫療保健)等公司是該市場的主要創新者。
COVID-19 影響分析
超音波換能器在大流行期間發揮了重要作用,特別是在評估 COVID-19 患者方面。床邊超音波(床邊超音波,POCUS)廣泛用於監測加加護病房(ICU)和急診的 COVID-19 患者的肺功能狀態、心臟功能和血管通路。這場大流行加速了照護端超音波(POCUS) 作為快速診斷和病患管理的寶貴工具的採用。醫療保健提供者已轉向使用包含高功率、一次性換能器的手持式超音波診斷設備,以最大程度地減少輻射暴露並改善患者照護。醫療保健系統和設施重視擁有現成的、攜帶式的和多功能的影像成像工具,例如超音波換能器,以應對未來的衛生緊急情況。Masu。總之,COVID-19 大流行對市場造成了短期破壞和長期變革影響。
市場成長要素
尖端醫療設備投資
醫療保健支出的增加是超音波換能器需求不斷成長的主要驅動力。醫療保健支出包括政府、醫療保健提供者、保險公司和個人為提供和獲得醫療保健服務而進行的投資。不斷成長的醫療保健支出使醫療機構和設施能夠分配預算來採購先進的醫療設備,包括超音波設備和換能器。這些投資旨在實現醫療基礎設施現代化並提高所提供的護理品質。不斷增加的醫療保健支出直接用於婦幼保健服務,而超音波是生產護理、監測胎兒發育和評估孕產婦健康狀況的基本工具。對婦女和兒童健康的關注推動了需求。
提高對超音波影像的認知
人們對超音波影像優勢的認知不斷提高,增加了超音波臨床應用的頻率和種類,在患者照護和醫學決策方面發揮關鍵作用。非侵入性和安全性是超音波換能器成為醫療保健領域首選診斷工具的兩個重要特性。這些屬性促進了超音波影像的廣泛採用和患者接受。超音波影像成像完全是非侵入性的,不需要插入儀器或使用電離輻射。這種非侵入性特性消除了手術切口的需要,並減少了相關的風險和併發症。超音波檢查不需要使用顯影劑,造影劑可能會引起某些人的過敏反應。這提高了安全性,特別是對於已知對顯影劑過敏的患者。所有這些都可能成為未來年度市場擴張的主要動力。
市場抑制因素
與先進感測器相關的高初期成本
與已開發國家相比,新興國家的財政資源往往較為有限,人均所得也較低。先進超音波設備的高昂初期成本使醫療保健預算緊張,並使醫療保健組織難以投資此類技術。發展中地區的醫療基礎設施往往不發達或裝備落後。將大部分預算分配給昂貴的影像影像設備可能被視為與其他緊迫的醫療保健優先事項的權衡。發展中地區可能擔心昂貴設備的長期永續性,例如備件和技術支援的可用性,並且可能不願意投資初期成本。這些因素很可能使超音波換能器市場未來的擴張變得困難。
產品類型展望
依產品類型分為線性、凸面、相控陣、端腔、CW多普勒等。 2022 年,相控陣細分市場在市場中佔據了重要的收益佔有率。相控陣換能器對於心臟成像,尤其心臟超音波圖至關重要。電子控制超音波束的能力可以實現心臟結構的精確可視化和心臟功能的即時評估。隨著心血管疾病(CVD)的增加,心臟超音波的需求顯著增加。血管超音波使用相控陣換能器來可視化動脈和靜脈等血管。
最終用途展望
根據最終用途,市場分為醫院、診所、診斷中心和門診手術中心(ASC)。 2022年,診所業務在市場中獲得了可觀的收益佔有率。診所強調預防醫學和健康檢查。超音波換能器可以篩檢乳癌、甲狀腺疾病、腹部疾病等,並實現早期發現和干涉,在預防保健中發揮重要作用。門診病人醫師擴大採用照護端超音波(POCUS) 來加強患者照護。
應用前景
依應用分類,市場分為心血管、普通影像、肌肉骨骼、婦產科、血管等。 2022 年,婦產科領域在市場中獲得了可觀的收益佔有率。婦產科超音波換能器使醫療保健提供者能夠監測整個懷孕期間的胎兒發育,從而有助於生產護理。評估胎兒生長、檢測異常、確定嬰兒位置並評估胎盤。準媽媽的父母可以透過超音波看到胎兒並與胎兒建立連結。隨著母親生產時年齡的增加,某些併發症的風險也會增加。高風險妊娠通常需要更頻繁和更先進的產前監測,包括超音波。
區域展望
從區域來看,市場分為北美、歐洲、亞太地區、拉丁美洲、中東和非洲。 2022 年,北美市場收益佔有率最高。北美擁有先進的醫療保健基礎設施,包括最先進的醫療設施、醫院、診所和診斷中心。該基礎設施對超音波換能器等先進醫療技術產生了強烈需求,以支援高品質的患者照護。該地區心血管病、糖尿病、肥胖等慢性病盛行率較高。超音波換能器對於這些慢性疾病的診斷、監測和管理至關重要,並有助於滿足不斷成長的需求。所有這些因素都可能支持未來北美市場的擴張。
The Global Ultrasound Transducer Market size is expected to reach $4.9 billion by 2030, rising at a market growth of 3.6% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,933.9 thousand units, experiencing a growth of 4.0% (2019-2022).
The demand for routine diagnostic imaging remains steady due to its essential role in healthcare. Consequently, the General Imaging segment registered a $1,329.6 million revenue in the market in 2022. General imaging transducers are ideal for routine diagnostic examinations. They are commonly used for general health assessments, such as evaluating abdominal organs, assessing the female reproductive system, and monitoring the progression of pregnancies. They are used to detect conditions like breast cancer, prostate cancer, and thyroid disorders early. The increasing emphasis on preventative healthcare drives the demand for these transducers. Therefore, the general imaging segment has the potential for high growth in the future.
The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance In July, 2022, GE HealthCare Technologies, Inc. released Voluson Expert 22, the most advanced ultrasound yet. The launched product would produce the best quality images and would provide greater flexibility in imaging functions. Additionally, In September, 2022, FUJIFILM Sonosite Inc. launched Sonosite LX system in several European countries, to support clinicians in using transoesophageal ultrasound at the point of care, both of which are created to be used with the Sonosite LX and Sonosite PX.
Based on the Analysis presented in the KBV Cardinal matrix; Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.) is the major forerunner in the Market. In October, 2020, Samsung Medison launched a new ultrasound system HERA W10 and prototype of a chair-type ultrasound system HERA I10, to deliver improved technology and offerings with a new level of image quality. Companies such as GE HealthCare Technologies, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and Hitachi, Ltd. (Hitachi Healthcare) are some of the key innovators in Market.
COVID-19 Impact Analysis
Ultrasound transducers were crucial in critical care settings during the pandemic, especially in assessing COVID-19 patients. Bedside ultrasound (point-of-care ultrasound or POCUS) was widely used to monitor lung conditions, cardiac function, and vascular access in COVID-19 patients in intensive care units (ICUs) and emergency departments. The pandemic accelerated the adoption of point-of-care ultrasound (POCUS) as a valuable tool for rapid diagnostics and patient management. Healthcare providers turned to handheld ultrasound devices, including high-powered, single-use transducers, to minimize exposure and enhance patient care. Healthcare systems and facilities emphasize having readily available, portable, and versatile imaging tools like ultrasound transducers to respond to future health emergencies. In conclusion, the COVID-19 pandemic had short-term disruptions and long-term transformative effects on the market.
Market Growth Factors
Advanced medical equipment investment
Increased healthcare spending is a significant driver behind the growing demand for ultrasound transducers. Healthcare spending encompasses investments made by governments, healthcare institutions, insurers, and individuals to provide and access healthcare services. Higher healthcare spending allows healthcare institutions and facilities to allocate budgets for procuring advanced medical equipment, including ultrasound machines and transducers. These investments aim to modernize healthcare infrastructure and improve the quality of care provided. Increased healthcare spending is directed toward maternal and child healthcare services, where ultrasound is a fundamental tool for prenatal care, monitoring fetal development, and assessing maternal health. This focus on women's and children's health will drive demand.
Growing awareness of ultrasound imaging
The growing awareness of the benefits of ultrasound imaging has led to more frequent and diverse clinical applications of ultrasound and has also played a pivotal role in shaping patient care and medical decision-making. Non-invasiveness and safety are two key attributes that make ultrasound transducers a preferred diagnostic tool in healthcare. These qualities contribute to the widespread adoption and patient acceptance of ultrasound imaging. Ultrasound imaging is entirely non-invasive, meaning it does not require the insertion of instruments or the use of ionizing radiation. This non-invasive nature eliminates the need for surgical incisions, reducing the associated risks and complications. Ultrasound does not require using contrast agents that can trigger allergic reactions in some individuals. This enhances safety, especially for patients with known allergies to contrast materials. All these will significantly drive the expansion of market in the coming years.
Market Restraining Factors
High upfront costs associated with advanced transducers
Developing regions often have limited financial resources and lower per capita income than developed countries. High upfront costs for advanced ultrasound equipment can strain healthcare budgets and make it difficult for healthcare institutions to invest in such technology. Healthcare infrastructure in developing regions may be underdeveloped or inadequately equipped. Allocating a significant part of the budget to expensive imaging equipment may be seen as a trade-off against other pressing healthcare priorities. Developing regions may have concerns about the long-term sustainability of expensive equipment, including the availability of spare parts and technical support, which can create reluctance to invest in advanced technology with high upfront costs. These elements will make it difficult for the ultrasonic transducer market to expand in the coming years.
Product Type Outlook
Based on product type, the market is divided into linear, convex, phased array, endocavitary, CW doppler, and others. The phased array segment procured a noticeable revenue share in the market in 2022. Phased array transducers are essential in cardiac imaging, particularly for echocardiography. Their ability to electronically steer the ultrasound beam allows for precise visualization of cardiac structures and real-time assessment of heart function. With the growing incidences of cardiovascular diseases (CVD), the demand for cardiac ultrasound has grown significantly. Vascular ultrasound relies on phased array transducers to visualize blood vessels, including arteries and veins.
End Use Outlook
By end use, the market is segmented into hospital, clinics, diagnostic center, and ambulatory surgery centers (ASCs). In 2022, the clinic segment acquired a substantial revenue share in the market. Clinics emphasize preventive medicine and health screenings. Ultrasound transducers play a vital role in preventative care by enabling screenings for conditions like breast cancer, thyroid disorders, and abdominal issues, allowing for early detection and intervention. Clinicians in outpatient settings increasingly adopt point-of-care ultrasound (POCUS) to enhance patient care.
Application Outlook
On the basis of application, the market is segmented into cardiovascular, general imaging, musculoskeletal, OB/GYN, vascular, and others. The OB/GYN segment acquired a significant revenue share in the market in 2022. OB/GYN ultrasound transducers are instrumental in prenatal care, allowing healthcare providers to monitor fetal development throughout pregnancy. They assess fetal growth, detect anomalies, determine the baby's position, and evaluate the placenta. Expectant parents rely on ultrasound scans for visualizing and bonding with their unborn child. As maternal age at childbirth increases, the risk of certain complications also rises. High-risk pregnancies often require more frequent and advanced prenatal monitoring, including ultrasound examinations.
Regional Outlook
Based on region, the market is divided into North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the highest revenue share in the market in 2022. North America boasts advanced healthcare infrastructure, including state-of-the-art medical facilities, hospitals, clinics, and diagnostic centers. This infrastructure creates a robust demand for advanced medical technologies like ultrasound transducers to support high-quality patient care. The region has a relatively high prevalence of chronic diseases, such as cardiovascular conditions, diabetes mellitus, and obesity. Ultrasound transducers are essential for diagnosing, monitoring, and managing these chronic illnesses, contributing to their growing demand. All these factors will assist in expanding the North America segment in the future.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Siemens Healthineers AG (Siemens AG), FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Canon, Inc. (Canon Medical Systems Corporation), Hitachi, Ltd. (Hitachi Healthcare), SonoScape Medical Corp., Koninklijke Philips N.V., Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Esaote SpA
Recent Strategies Deployed in Ultrasound Transducer Market
Product Launches and Product Expansions
Jan-2023: FUJIFILM Sonosite, Inc. revealed the Sonosite PX ultrasound system. The newest version of Sonosite POCUS, called Sonosite PX, offers the highest level of visual quality ever seen in a Sonosite system, as well as a number of features that help with workflow efficiency and a flexible form factor. The device offers a novel and adjustable work surface that can be employed in a horizontal or vertical position depending on the situational needs of the exam in order to increase clinician ergonomics and productivity.
Nov-2022: Philips released the compact 5000 series, a new compact ultrasound system. The Compact 5000 series make it easier for more patients to have their ultrasound exams done correctly the first time around because of its portability and versatility without sacrificing image quality or performance.
Sep-2022: FUJIFILM Sonosite Inc. launched Sonosite LX system in several European countries. Following this launch, the company also released T8-3 transoesophageal transducer and Cardiac Resuscitation exam type to support clinicians in using transoesophageal ultrasound at the point of care, both of which are created to be used with the Sonosite LX and Sonosite PX.
Jul-2022: GE HealthCare Technologies, Inc. released Voluson Expert 22, the most advanced ultrasound yet. The launched product would produce the best quality images and would provide greater flexibility in imaging functions.
Jun-2022: Mindray unveiled TEX20 Series, best-in-class Point of Care ultrasound system. With its patient-centred information solution, extraordinary image clarity, clinically oriented workflow, smart tools, and intelligent design, this ground-breaking point of care system, the TEX20 Series, dramatically alters the conventional perspective of POC ultrasonography from its predecessors. It offers all the details needed to make decisions for follow-up and quality control.
May-2021: Esaote launched the new MyLab X9 ultrasound system. This system provides the top level of image quality and data processing capability, utilizing the new technological solutions to explore the latest frontiers of ultrasound imaging.
Mar-2021: GE Healthcare today unveiled Venue Fit, a streamlined and compact POCUS system, alongside an industry-first AI offering for cardiac imaging. The Venue Fit is the smallest system in the Venue Family from GE Healthcare, with a tiny footprint designed to fit in confined places, an easy-to-clean touchscreen, and straightforward scanning tools. The new Venue Fit ultrasound device enables healthcare professionals who work in constrained areas to get immediate imaging insights.
Mar-2021: GE Healthcare released Vscan Air, hand-held ultrasound device. The new product is completely wireless, links to a smartphone app, and enables patients to safely access the images. Trained healthcare professionals can use the gadget to immediately test blood flow, and gallbladder illness, and analyze and monitor Covid-19 through a lung exam.
Mergers & Acquisition
Jul-2023: Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announced an agreement to acquire a 75% equity interest in DiaSys Diagnostic Systems GmbH. Through this acquisition, Mindray would significantly strengthen its international supply chain infrastructure and assist the expansion of our IVD business into medium- to large-sized customer sectors. Both companies will work together to realize synergies and increase value for our customers.
Sep-2021: GE Healthcare completed the acquisition of BK Medical, a company that offers ultrasound technology. The acquisition would help GE Healthcare expand its ultrasound offerings into surgical visualization and fuel the growth in precision health.
Partnerships, Collaborations & Agreements
Sep-2021: GE Healthcare joined hands with UltraSight, a digital health pioneer transforming cardiac imaging through the power of AI. The images of an astronaut's heart in microgravity would be captured using the real-time AI guidance software of UltraSight and the portable GE Vscan AirTM, a high-performance, wireless pocket-sized color ultrasound from GE Healthcare.
Jan-2021: Hitachi entered into an agreement with Olympus Corporation, a manufacturer of optics and reprography products. With this agreement, the company aimed to offer better diagnostic and treatment to patients and healthcare professionals.
Market Segments covered in the Report:
By Product Type (Volume, Thousand Units, USD Million, 2019-2030)
By End Use (Volume, Thousand Units, USD Million, 2019-2030)
By Application (Volume, Thousand Units, USD Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research